CDSCO Test License for Medical Devices

A test licence authorises import for a defined, non-commercial purpose: laboratory testing, performance evaluation, demonstration and training, or use in a clinical investigation. The quantity you can import is tied to that purpose — enough to run the tests or the trial, not enough to seed a market. This is the point people most often get wrong. A test licence is not a shortcut to selling; it is a controlled way to bring product in for a specific reason.

Because the licence is purpose-bound, the application has to explain that purpose convincingly and justify the quantity against it. A request for fifty units to run a handful of bench tests will attract questions. We frame the purpose and quantity so the application reads as reasonable and gets through review without a fight.

• Allowed: testing, evaluation, demonstration, training, clinical use.
• Not allowed: commercial sale or distribution of the imported units.
• Quantity must match the stated purpose — over-asking triggers queries.

For most manufacturers the test licence is not a standalone exercise — it is the first move in a longer game. India-specific testing or clinical performance data generated under a test licence often feeds directly into the technical file for a full import or manufacturing licence. Getting the device in early, running the work, and building that evidence in parallel can shave real time off your overall market-entry timeline.

It also lets your commercial team put the actual device in front of hospitals and distributors at demonstrations and conferences while the commercial licence is still being processed. We plan the test licence with the end goal in view, so the data and experience you gather actually count towards the registration that follows.

A test licence only helps if the shipment actually clears. The most common cause of a held consignment is a mismatch between the licence and the invoice — a different quantity, a slightly different device description, or a manufacturer name that does not match. Customs officers check these against the MD-17 before releasing goods, and a discrepancy means the shipment sits until it is resolved.

We make sure the application, the licence and the shipping documents all agree, and we coordinate with your customs broker so the paperwork presented at the port matches the licence exactly. It is an unglamorous detail that decides whether your samples arrive on schedule or languish in a bonded warehouse.

A test licence is quicker than a full import licence — it is generally processed in around one to three months, depending on the device and how completely the purpose is justified. The MD-17 is valid for the period stated on it, tied to the testing or trial timeline, and can be applied for again if the work runs longer. Because it is faster and lower-stakes than the MD-15, it is a practical way to keep a project moving while the commercial licence is prepared.

• Typical processing: about 1–3 months, faster than a full import licence.
• Validity is tied to the stated testing or trial period.
• Feeds India-specific data into your later CDSCO registration.

When a device needs India-specific clinical evidence — often the case for higher-risk Class C and D products, or where CDSCO wants local performance data — a test licence is how the investigational devices get into the country. The import is tied to an approved clinical investigation: the site, the number of subjects, and the device quantity all have to hang together, and the licence quantity is justified against the trial protocol rather than a commercial forecast.

This makes the clinical-use test licence a little more involved than a simple bench-testing import. The application has to align with the clinical investigation approval and the ethics-committee clearances, and the quantity has to be traceable to the number of subjects and devices the protocol calls for. Mismatches between the trial documents and the import application are a common source of queries, so the two have to be prepared as one package rather than stitched together afterwards.

We coordinate the test licence with the clinical side so the investigational devices arrive when the sites are ready to enrol, not before and not after. Getting this timing right matters — investigational stock that clears customs weeks late can stall a trial and push out every downstream milestone, including the commercial registration the trial is meant to support.

People often ask whether they should just wait for the full import licence instead of bothering with a test licence. The answer depends on what you actually need to do. If you need to sell, only an MD-15 import licence or a manufacturing licence will do, and a test licence is a detour. But if you need to run bench tests, generate India-specific data, demonstrate the device to hospitals, train staff, or supply an ongoing clinical investigation, the test licence gets product in the country months before the commercial licence would, and for a narrower, cheaper application.

The smart play, for most higher-risk devices, is to run both in parallel: a test licence to get devices in and start generating evidence now, and the full registration progressing alongside it, fed by the data the test work produces. Treated this way the test licence is not extra work — it compresses your overall timeline by letting the evidence-gathering and the licensing happen at the same time rather than one after the other.

Where we add the most value is in judging which route — or which combination — actually fits your commercial goal, so you are not paying for a full import dossier when a test licence would have unblocked the project, nor stuck on a test licence when what you really needed was the commercial one. That judgement call at the start is worth more than it looks.

A test licence comes with a quiet obligation that catches people out: you are expected to account for what you did with the devices you imported. Because the import was granted for a specific purpose and quantity, the regulator can ask you to show that the units were actually used for testing, evaluation or the trial you named — not quietly diverted into the market. Keeping clean records of receipt, use and disposal is part of holding a test licence responsibly, and it also protects you if questions ever arise.

We set up a simple record-keeping approach at the start so this is never a scramble later: where the devices went, how they were used, and what happened to any that were consumed or returned. It takes very little effort when it is built in from day one, and it means that if your test-licence activity is ever reviewed — or referenced in your later commercial application — the paper trail is already clean and complete.